Samjin Pharmaceutical Co. Ltd. has disclosed stimulator of interferon genes protein (STING; TMEM173) agonists reported to be useful for the treatment of cancer, allergy, autoimmune diseases and ...

The fatality is considered to be related to the drug treatment, according to the biotech, which is developing the STING agonist in collaboration with GSK under the terms of a $1.3 billion option ...

An innovative nano-immune agonist has been developed to significantly ... via the synergistic action of cuproptosis and cGAS-STING enhanced immune response Go to source). The study, recently ...